This pilot study will evaluate the feasibility of implementing a structured digital patient-reported assessment pathway in adults aged 65 years or older with acute leukemia. Following activation of the institutional MiAsturSalud/SESPA platform, participants will complete the EORTC QLQ-C30 and FACT-Leu remotely after the baseline visit and will repeat the digital assessment at 3-6 months. The primary outcome will be completion of at least 80% of the baseline digital assessment within 7 days. Secondary outcomes will be caregiver assistance requirement, non-completion of the planned digital follow-up assessment, and elapsed completion time. The study is not designed to establish clinical efficacy.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Enrollment
20
Following activation of the MiAsturSalud/SESPA digital pathway, participants will complete the EORTC QLQ-C30 and FACT-Leu remotely after the baseline visit. The baseline digital assessment will be scheduled within 48-72 hours, with an outcome assessment window extending to 7 days. A second digital assessment will be scheduled at 3-6 months. The platform will record questionnaire completion status and elapsed completion time, and caregiver assistance will be documented. The pathway will not generate automated clinical alerts or mandate changes to treatment.
Hospital Universitario Central de Asturias (HUCA)
Oviedo, Principality of Asturias, Spain
Feasibility of Digital Implementation
Proportion of participants completing at least 80% of all required items across the EORTC QLQ-C30 and FACT-Leu baseline digital questionnaire battery.
Time frame: Within 7 days after baseline.
Caregiver Assistance Requirement
Proportion of participants requiring practical caregiver assistance to access or navigate the platform, read questionnaire content or enter responses selected by the participant. Independent proxy completion will not be permitted.
Time frame: Within 7 days after baseline.
Non-completion of Planned Digital Follow-up Assessment
Proportion of participants who do not complete the planned digital follow-up assessment at 3-6 months. Reasons for non-completion will be categorised where ascertainable, including voluntary withdrawal, technical difficulties, clinical deterioration, disease progression, hospitalisation, death and loss to follow-up.
Time frame: From baseline to 3-6 months.
Time Required for Digital Completion
Elapsed time, in minutes, required to complete the baseline digital questionnaires.
Time frame: Within 7 days after baseline.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.